Company intelligence / Profile preview
Pharmaselect International
Vienna, Austriapharmaselect.com ↗
- Ownership
- Private
- Employees
- ~51
- Development stage
- Other
01
Overview
Pharmaselect has an active commercial portfolio of specialty and generic pharmaceuticals in Central-Eastern Europe, focused on ophthalmology, neurology, rheumatology and hospital niche products. The pipeline is built by acquiring older branded drugs from larger companies and adding select generics, especially for specialist and hospital prescribers[1][3][5][9].
- Therapeutic areas
- RheumatologyOphthalmologyInfectious DiseasesOtherNeurology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Beyond the preview
Go deeper on Pharmaselect International.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pharmaselect International.